subgroup of
drug)
→
ReceivesAction
→
approved in 2017
| Typicality: | 0.280 |
| Saliency: | 0.071 |
| new drug → be approved in → 2017 | 4 |
| negative | neutral | positive |
| 0.013 | 0.511 | 0.476 |
| Raw frequency | 4 |
| Normalized frequency | 0.071 |
| Modifier score | 0.500 |
| Perplexity | 247.173 |